Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Trough concentration of itraconazole and its relationship with efficacy and safety: a systematic review and meta-analysis

Jingru Zhang,1,2 Yiwei Liu,1 Xiaolu Nie,1 Yuncui Yu,1 Jian Gu,3 Libo Zhao1 1Clinical Research Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China; 2Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Sciences,...

Full description

Bibliographic Details
Main Authors:	Zhang J, Liu Y, Nie X, Yu Y, Gu J, Zhao L
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-08-01
Series:	Infection and Drug Resistance
Subjects:	itraconazole trough concentration efficacy safety meta-analysis
Online Access:	https://www.dovepress.com/trough-concentration-of-itraconazole-and-its-relationship-with-efficac-peer-reviewed-article-IDR

Similar Items

Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial
by: Shenoy MM, et al.
Published: (2023-09-01)

Efficacy of Super-Bioavailable Itraconazole and Conventional Itraconazole at Different Dosing Regimens in Glabrous Tinea Infection - A Randomized Clinical Trial [Corrigendum]
by: Shenoy MM, et al.
Published: (2023-09-01)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
by: Dhiraj Dhoot, et al.
Published: (2023-01-01)

Gender differences in concentration of itraconazole and hydroxyitraconazole
by: Stanojković Tijana, et al.
Published: (2021-01-01)

Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacy
by: Yichang Zhao, et al.
Published: (2024-01-01)

Comparative efficacy and safety of super-bioavailable itraconazole-130 mg once daily in obese and non-obese patients of glabrous tinea
by: Manjunath Shenoy, et al.
Published: (2023-01-01)

In vitro/in vivo performance of different complexes of itraconazole used in the treatment of vaginal candidiasis
by: Mohammad Aamir Mirza, et al.
Published: (2012-12-01)

Performance Simulation of Solar Trough Concentrators: Optical and Thermal Comparisons
by: Fei Cao, et al.
Published: (2023-02-01)

Comparison of Efficacy and Safety between Super-bioavailable Itraconazole and Conventional Itraconazole in the Treatment of Tinea Infection of Glabrous Skin – A Randomised Observer-blinded Pilot Study
by: Liza Mohapatra, et al.
Published: (2023-09-01)

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Flávio Queiroz-Telles, et al.

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Queiroz-Telles Flávio, et al.
Published: (2001-01-01)

A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis
by: Trivedi N, et al.
Published: (2010-01-01)

Design and Evaluation of Polygonal Trough Solar Concentrator
by: Yasser Yassin Khudair, et al.
Published: (2021-10-01)

Variability of Tacrolimus Trough Concentration in Liver Transplant Patients: Which Role of Inflammation?
by: Anaelle Chavant, et al.
Published: (2021-11-01)

Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis
by: Priyanka Sharma, et al.
Published: (2020-10-01)

Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis
by: Yuki Hanai, et al.
Published: (2021-04-01)

A randomized control study of oral itraconazole versus itraconazole with terbinafine in the treatment of dermatophytosis
by: Divya Sharma, et al.
Published: (2023-01-01)

Significant elevation of free itraconazole concentration at onset of adverse effects: A case report
by: Ryota Tanaka, et al.
Published: (2021-03-01)

Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
by: Xiaozhi Lv, et al.
Published: (2022-09-01)

Effectiveness, safety, and tolerability of itraconazole oral solution in pediatric dermatophytosis
by: M Ramesh Bhat, et al.
Published: (2020-01-01)

An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients
by: Huang X, et al.
Published: (2021-04-01)

The effect of itraconazole on treatment of vaginal candidiasis
by: A Moemeni, et al.
Published: (1995-03-01)

Safety of linezolid in patients with decreased renal function and trough monitoring: a systematic review and meta-analysis
by: Xiaoxi Liu, et al.
Published: (2022-11-01)

Corrigendum: Effect of itraconazole on the safety and pharmacokinetics of antitumor SHR6390
by: Xiaozhi Lv, et al.
Published: (2024-04-01)

Evaluation of the variability and safety of serum trough concentrations of vancomycin in patients admitted to the intensive care unit
by: Xiaodan Qian, et al.
Published: (2017-07-01)

Variability of Isavuconazole Trough Concentrations during Longitudinal Therapeutic Drug Monitoring
by: Léa Bolcato, et al.
Published: (2022-09-01)

The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing
by: Moeko Tsutsuura, et al.
Published: (2021-02-01)

Esporotricose cutânea experimental: Avaliação in vivo do itraconazol e terbinafina Experimental cutaneous sporotrichosis: in vivo evaluation of itraconazole and terbinafine
by: Tatiana de Ávila Antunes, et al.
Published: (2009-12-01)

Association between anlotinib trough plasma concentration and treatment outcomes in advanced non-small-cell lung cancer
by: Ling Chen, et al.
Published: (2023-03-01)

A New Two-Foci V-Trough Concentrator for Small-Scale Linear Fresnel Reflectors
by: Alberto Pardellas, et al.
Published: (2023-02-01)

Nonimaging High Concentrating Photovoltaic System Using Trough
by: Waseem Iqbal, et al.
Published: (2023-01-01)

Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC
by: Judith L. Gulikers, MSc, et al.
Published: (2024-04-01)

Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
by: Ori Hassin, et al.
Published: (2021-02-01)

Successful treatment of chromoblastomycosis using cryosurgery in association with low-dose itraconazole
by: Talira Caserta Gon, et al.
Published: (2023-03-01)

Suscetibilidade in vitro de isolados de Sporothrix schenckii frente à terbinafina e itraconazol In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole
by: Ana Raquel Mano Meinerz, et al.
Published: (2007-02-01)

Desenvolvimento e validação de metodologia analítica para determinação de itraconazol em produtos farmacêuticos por CLAE Development and validation of the methodology for evaluation of itraconazole in pharmaceutical products by HPLC
by: Edith Cristina Laignier Cazedey, et al.
Published: (2007-08-01)

Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea
by: Shah B, et al.
Published: (2023-04-01)

Efficacy and safety of adding low-dose isotretinoin to itraconazole in the treatment of chronic recurrent dermatophytosis among sample of Iraqi patients: An open-labelled therapeutic clinical comparative study
by: Dooha K Alhamdi, et al.
Published: (2022-01-01)

Hyalohyphomycosis (Fusariosis): Atypical presentation in an immunocompetent individual responding to itraconazole
by: Deepthi Konda, et al.
Published: (2024-01-01)

Chromoblastomycosis: tissue modifications during itraconazole treatment
by: Kátia Sheylla Malta Purim, et al.
Published: (2017-08-01)